drugset / Trial / NCT05367336

Platelet Reactivity With Fentanyl, Morphine, or no Narcotic

NCT05367336 ↗

Phase 2 Terminated 21 enrolled Corewell Health South
Non-randomizedParallel-groupOpen-labelTreatment

Summary

The goal is to determine whether fentanyl and morphine have similar effects in reducing aspirin's effect upon platelets in emergency department patients with chest discomfort. Morphine has been shown to worsen outcomes in heart attack patients due to reduction of oral anti-platelet agent effectiveness and so many providers have switches to using fentanyl. However, it is largely unknown whether fentanyl has similar effects.

Timeline

Start
2022-08-31
Primary completion
2025-02-18
Completion
2025-02-18

Outcome

Outcome not reported

Stopped (Enrollment): “The study was halted prematurely due to difficulties in recruiting a sufficient number of participants. Despite efforts to enroll eligible individuals, the recruitment goals were not met, making it infeasible to continue the study as planned.”

Drugs

EvaluationDrugModalityDoseRoute
Subject Fentanyl Other / unclassified — —
Subject Morphine Other / unclassified — —